3-iodobenzylguanidine has been researched along with Rhabdomyosarcoma 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosini, V; Boschi, S; Fanti, S; Lopci, E; Zanoni, L | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Rhabdomyosarcoma 2
| Article | Year |
|---|---|
Alveolar rhabdomyosarcoma with neuroendocrine differentiation detected by Ga-68 DOTA-NOC PET/CT: a case report.
Topics: 3-Iodobenzylguanidine; Cell Differentiation; Child; Female; Humans; Multimodal Imaging; Neurosecretory Systems; Organometallic Compounds; Positron-Emission Tomography; Rhabdomyosarcoma, Alveolar; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |